Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FutureShape Family
NCT07872904Phase 4Recruiting
- Start
- Oct 2026
- Primary completion
- May 2030
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, Overweight. Started Oct 2026; status: recruiting.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07872904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07872904.